In the present study, ASKI-1 inhibitor GS-4977 attenuated the inhibitory effects of TRAIL up-regulation on the viability, invasion, migration, and ferroptosis of NSCLC cells. The gene discussed is TNFSF10; the disease is non-small cell lung carcinoma.